Neurocrine Biosciences Inc (NBIX)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	249,700	154,500	89,600	407,300	37,000
Revenue	US$ in thousands	1,883,200	1,411,600	1,107,700	994,700	756,124
Net profit margin		13.26%	10.95%	8.09%	40.95%	4.89%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $249,700K ÷ $1,883,200K
= 13.26%

Neurocrine Biosciences, Inc.'s net profit margin has exhibited fluctuations over the past five years. The company's net profit margin was highest in 2020 at 38.94%, indicating that for every dollar of revenue generated, the company retained $0.3894 as profit after accounting for all expenses. This exceptionally high margin in 2020 may have been driven by various factors such as cost management, revenue growth, or one-time events.

In contrast, the net profit margin dropped significantly to 4.70% in 2019, reflecting lower profitability compared to the other years. This decline could suggest challenges in controlling costs or generating sufficient revenue to cover expenses.

Subsequently, there was an upward trend in the net profit margin from 2019 to 2023, with improvements year-over-year. The margin increased to 7.90% in 2021, 10.38% in 2022, and further rose to 13.23% in 2023. These increments indicate the company's efforts in enhancing operational efficiency, managing costs effectively, and potentially increasing revenue streams.

Overall, Neurocrine Biosciences, Inc.'s net profit margin trend reflects variability and improvements over the years, showcasing the company's ability to adapt to changing market conditions and optimize profitability.